Sunrest Lifescience Ltd
Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products[1]
- Market Cap ₹ 21.5 Cr.
- Current Price ₹ 50.0
- High / Low ₹ 75.0 / 44.6
- Stock P/E 10.7
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 33.41 | |
| 30.38 | |
| Operating Profit | 3.03 |
| OPM % | 9.07% |
| 0.00 | |
| Interest | 0.31 |
| Depreciation | 0.10 |
| Profit before tax | 2.62 |
| Tax % | 23.28% |
| 2.01 | |
| EPS in Rs | 4.68 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 1.43 | |
| -1.15 | |
| -0.33 | |
| Net Cash Flow | -0.04 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Documents
Announcements
-
Outcome of Board Meeting
30 May 2025 - Sunrest Lifescience approved FY25 audited results; profit ₹199.98L, revenue ₹3312.24L, unmodified audit opinion.
-
Outcome of Board Meeting
30 May 2025 - Approved audited financial results for year ended March 31, 2025; profit ₹199.98L, revenue ₹3312.24L.
-
Updates
14 May 2025 - Sunrest Lifescience confirms non-applicability of SEBI large corporate debt issuance rules as of March 31, 2025.
-
Board Meeting Intimation
13 May 2025 - SUNREST LIFESCIENCE LIMITED has informed about Board Meeting to be held on 27-May-2025 to inter-alia consider and approve the Audited Financial results of the Company …
-
Disclosure under SEBI Takeover Regulations
9 May 2025 - Promoters declare no encumbrance on shares for FY ended March 31, 2025 under SEBI regulations.
Business Overview:[1][2]
SLSL is in the business of trading of Pharmaceutical Product on wholesale and retail basis. It provides OTC brands in healthcare & personal care viz. Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste